$Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*$

Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*

Wendtner, Clemens M.; Hallek, Michael; Fraser, Graeme A. M.; Michallet, Anne-Sophie; Hillmen, Peter; Dürig, Jan; Kalaycio, Matt; Gribben, John G.; Stilgenbauer, Stephan; Buhler, Andreas; Kipps, Thomas J.; Purse, Brendan; Zhang, Jennie; De Bedout, Sabine; Mei, Jay; Chanan-Khan, Asher

期刊名称Leukemia & Lymphoma
作者Wendtner, Clemens M.; Hallek, Michael; Fraser, Graeme A. M.; Michallet, Anne-Sophie; Hillmen, Peter; Dürig, Jan; Kalaycio, Matt; Gribben, John G.; Stilgenbauer, Stephan; Buhler, Andreas; Kipps, Thomas J.; Purse, Brendan; Zhang, Jennie; De Bedout, Sabine; Mei, Jay; Chanan-Khan, Asher
印刷ISSN1042-8194
电子ISSN1029-2403
文件大小1247.77KB
发表时间2016-01-14
DOI10.3109/10428194.2015.1128540
页码1-9

发现好书期刊，享受阅读乐趣

Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*